Abstract: The present invention relates to peptides comprising the amino acid sequence having a sequence identity of at least 70% with SEQ ID NO: 1, provided that said peptides do not have the amino acid sequence SEQ ID NO: 2 or SEQ ID NO: 3, and that the cysteine at position 6 of SEQ ID NO: 1 remains unchanged. The invention also relates to a pharmaceutical composition thereof and to its uses in the treatment of tumours, in particular, in the treatment of cancer and metastases.

Abstract: In this work is presented a method for fabrication of high-aspect ratio structures through spalling effect. The spalling is achieved through lithography, etching and sputtering processes, thus providing the flexibility to position the spalled structures according to the application requirements. This method has been successfully demonstrated for metal-oxides and metals. The width of the fabricated structures is dependent on the thickness of the film deposited by sputtering, where structures as small as 20 nm in width have been obtained.

Abstract: A fiber-optic salinity and temperature measurement includes a first Fabry-Perot interferometer and a second Fabry-Perot interferometer. Each of the Fabry-Perot interferometers includes a first optical fiber fusion spliced to a second optical fiber such that a relatively large cavity is formed between the fibers. The relatively large cavity forms the measurement chamber for each Fabry-Perot interferometer. The input port on each of the Fabry-Perot interferometers is coupled to an optical splitter such that a single optical signal input is provided to each Fabry-Perot interferometer. The output port on each of the Fabry-Perot interferometers is coupled to an optical combiner that combines the interference signal received from each of the Fabry-Perot interferometers. An optical signal analyzer coupled to an output port of the optical combiner determines the salinity and temperature of a sample material in the large cavity of the second Fabry-Perot interferometer.